{"DataElement":{"publicId":"2006170","version":"1","preferredName":"Protocol North American Brain Tumor Consortium Identifier Number","preferredDefinition":"the Cooperative Group-specific alphanumeric identifier assigned to an NCI-sponsored protocol by the North American Brain Tumor Consortium (NABTC).","longName":"PROT_NABTC_ID_NUM","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195036","version":"1","preferredName":"Protocol North American Brain Tumor Consortium Identifier","preferredDefinition":"information related to the protocol's NABTC ID.","longName":"PROT_NABTC_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2176994","version":"1","preferredName":"Protocol","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"Protocol","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AC7-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660781","version":"1","preferredName":"North American Brain Tumor Consortium Identifier","preferredDefinition":"The North American Brain Tumor Consortium is dedicated to the development and conduct of innovative clinical trials that will ultimately result in a cure for patients with malignant brain tumors. Their goals are 1) to discover new and effective therapies for the treatment of patients with brain tumors, including anti-angiogenesis drugs, differentiating agents, anti-invasive medications, and new molecular agents such as gene therapy; 2) to develop innovative combination strategies to enhance the therapeutic effects of chemotherapy and radiation treatments; and 3) to develop and fund translational research opportunities that will bring exciting new agents and strategies from the laboratory to the clinical setting. (http://www.nabtc.org):One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C37995:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"North American Brain Tumor Consortium","conceptCode":"C37995","definition":"Dedicated to the development and conduct of innovative clinical trials that will ultimately result in a cure for patients with malignant brain tumors. Their goals are 1) to discover new and effective therapies for the treatment of patients with brain tumors, including anti-angiogenesis drugs, differentiating agents, anti-invasive medications, and new molecular agents such as gene therapy; 2) to develop innovative combination strategies to enhance the therapeutic effects of chemotherapy and radiation treatments; and 3) to develop and fund translational research opportunities that will bring exciting new agents and strategies from the laboratory to the clinical setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-D17D-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EBC19B2D-D95E-603E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018389","version":"1","preferredName":"Protocol Identifier Number","preferredDefinition":"the numeric or alphanumeric identification assigned to the study by the National Cancer Institute.","longName":"PROT_ID_NUM","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008529","version":"1","preferredName":"Research Protocols","preferredDefinition":"the identification of cancer research protocols.","longName":"RSCH_PROT","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECC2BE-2F27-348A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184315","version":"1","preferredName":"Number","preferredDefinition":"Number; a concept of quantity derived from zero and units; a numeral or string of numerals that is used for identification.","longName":"Number","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Number","conceptCode":"C25337","definition":"A numeral or string of numerals expressing value, quantity, or identification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1E43-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3A8191F-BCD8-233F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"CAMPBELB","dateModified":"2007-03-19","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"},{"publicId":"2812583","version":"1","longName":"Panvec","context":"NCIP"}]},{"publicId":"2190530","version":"1","longName":"Demonstration Applications","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812349","version":"1","longName":"Rembrandt","context":"NCIP"}]}],"AlternateNames":[{"name":"PROT_NABTC_ID_NUM","type":"USED_BY","context":"NCIP"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"NABTC Protocol Number","url":null,"context":"CTEP"},{"name":"NABTC Study No.","type":"Preferred Question Text","description":"NABTC Study No.","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B3D263CB-1EC3-16C8-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-09","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-09","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}